Neurosurgery

Treatment: Standard of Care and Transsphenoidal Surgery

At a Glance

Transsphenoidal surgery (TSS) is the standard treatment for Cushing disease. The goal of this specialized procedure is to remove the pituitary tumor through the nasal passage, causing cortisol levels to drop drastically and achieving biochemical remission.

The international standard of care for Cushing disease is a specialized procedure called transsphenoidal surgery (TSS) ^[1]. Because the pituitary gland is located at the base of the brain, surgeons do not need to open the skull; instead, they reach the tumor through the nasal passage and the sphenoid sinus ^[2].

The primary goal of this surgery is twofold: to remove the tumor (the PitNET) and to restore your body’s hormone balance.

Defining Success: The “Remission Zone”

In most surgeries, “success” means the problem is gone. In Cushing disease, success is measured by how low your cortisol levels drop in the days immediately following the operation ^[3].

Doctors look for a state called biochemical remission. When the tumor is successfully removed, the remaining normal pituitary gland is often “asleep” and won’t produce hormones right away. This causes your cortisol levels to plummet, which—counterintuitively—is exactly what your team wants to see ^[4].

The Benchmark: Most major pituitary centers look for a morning serum cortisol level of less than 2 to 5 µg/dL (or <50 nmol/L) within the first 1 to 5 days after surgery ^[5]^[6].
The Nadir: Your “nadir” is the lowest point your cortisol reaches. While some patients drop immediately on Day 1, for others, it may take until Day 3 to reach this low point ^[7].
The “Crash”: Reaching these low levels often makes patients feel very ill (nausea, joint pain, extreme fatigue). While uncomfortable, these symptoms—known as cortisol withdrawal—are often a sign that the high-hormone source has been removed ^[8].

Factors That Influence Outcomes

While TSS is highly effective, several factors can make the surgery more complex or reduce the chances of immediate remission:

Tumor Size: Success rates are significantly higher for microadenomas (tumors smaller than 10mm) compared to macroadenomas (larger than 10mm) ^[9]^[10].
Invasion: If the tumor has grown into the cavernous sinus (a nearby area containing major blood vessels and nerves), it is much harder for the surgeon to remove every single cell without causing damage ^[10].
Tumor Consistency: Some tumors are soft and easy to remove, while others are firm or “fibrous,” making it difficult to separate them from the healthy pituitary gland ^[10].

What If the Cortisol Stays High?

If your cortisol levels do not drop into the remission zone after surgery, it usually indicates residual tumor—meaning a small amount of the ACTH-secreting tissue remains ^[11].

This does not mean you are out of options. In these cases, your multidisciplinary team may discuss:

Repeat Surgery: Sometimes a second look can find a small piece of tissue missed during the first operation ^[12].
Medical Therapy: Medications to block cortisol production ^[13].
Radiation: To target any remaining microscopic tumor cells ^[14].

The journey to health in Cushing disease is often a marathon, not a sprint. Achieving biochemical remission is the first and most important milestone in that race ^[15].

Common questions in this guide

What is transsphenoidal surgery for Cushing disease?

Transsphenoidal surgery is a specialized procedure used to remove a pituitary tumor through the nasal passage and sphenoid sinus. This approach allows surgeons to reach the tumor at the base of the brain without having to open the skull.

What does biochemical remission mean after Cushing surgery?

Biochemical remission means your morning cortisol levels have plummeted to very low levels within a few days after surgery. This drastic drop indicates that the tumor causing excess hormone production has been successfully removed.

Why do I feel worse right after my Cushing disease surgery?

You may experience a 'crash' involving nausea, joint pain, and extreme fatigue due to sudden cortisol withdrawal. While uncomfortable, these symptoms are often a positive sign that your cortisol levels have successfully dropped.

What happens if my cortisol levels stay high after surgery?

If cortisol remains high, it usually means a small amount of the tumor was left behind. Your medical team will discuss next steps, which could include a second surgery, medications to block cortisol production, or radiation therapy.

Does the size of my pituitary tumor affect the surgery's success?

Yes, surgical success rates are significantly higher for microadenomas, which are tumors smaller than 10 millimeters. Larger tumors or those that have grown into nearby areas like the cavernous sinus are more difficult to remove completely.

Curated prompts to bring to your next appointment.

1.What was my lowest morning cortisol level in the first 72 hours after surgery, and how does that relate to your definition of remission?
2.During the procedure, did you see any signs that the tumor had invaded the cavernous sinus or bone?
3.If my cortisol doesn't drop to the 'remission zone' (<5 µg/dL), how long do we wait before considering a second surgery or other treatments?
4.What is your surgical volume for Cushing disease specifically, and what is your personal remission rate for microadenomas?
5.How will we manage my medications if I achieve remission and enter a state of 'adrenal insufficiency'?

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References (15)

1
Cushing's disease.
Ferriere A, Tabarin A
Presse medicale (Paris, France : 1983) 2021; (50(4)):104091 doi:10.1016/j.lpm.2021.104091.
PMID: 34718112
2
Cushing Disease: Medical and Surgical Considerations.
Bray DP, Rindler RS, Dawoud RA, et al.
Otolaryngologic clinics of North America 2022; (55(2)):315-329 doi:10.1016/j.otc.2021.12.006.
PMID: 35256173
3
Early postoperative LDDST enhances remission prediction beyond morning cortisol in cushing's disease.
Nasi-Kordhishti I, Oberle L, Goloshchapova K, Honegger J
Pituitary 2026; (29(1)):40.
PMID: 41663683
4
Postoperative Day 1 Morning Cortisol Value as a Biomarker to Predict Long-term Remission of Cushing Disease.
Wang F, Catalino MP, Bi WL, et al.
The Journal of clinical endocrinology and metabolism 2021; (106(1)):e94-e102 doi:10.1210/clinem/dgaa773.
PMID: 33108450
5
Consensus-driven in-hospital cortisol assessment after ACTH-secreting pituitary adenoma resection.
Stolyarov Y, Mirocha J, Mamelak AN, Ben-Shlomo A
Pituitary 2018; (21(1)):41-49 doi:10.1007/s11102-017-0845-3.
PMID: 29143885
6
Outcomes of endoscopic transsphenoidal surgery for Cushing's disease.
Brady Z, Garrahy A, Carthy C, et al.
BMC endocrine disorders 2021; (21(1)):36 doi:10.1186/s12902-021-00679-9.
PMID: 33658018
7
Dynamics of postoperative serum cortisol after transsphenoidal surgery for Cushing's disease: implications for immediate reoperation and remission.
Mayberg M, Reintjes S, Patel A, et al.
Journal of neurosurgery 2018; (129(5)):1268-1277.
PMID: 29271716
8
Factors predicting the duration of adrenal insufficiency in patients successfully treated for Cushing disease and nonmalignant primary adrenal Cushing syndrome.
Prete A, Paragliola RM, Bottiglieri F, et al.
Endocrine 2017; (55(3)):969-980 doi:10.1007/s12020-016-1007-5.
PMID: 27395418
9
Outcome of Transsphenoidal Surgery for Cushing Disease: A Single-Center Experience Over 32 Years.
Chandler WF, Barkan AL, Hollon T, et al.
Neurosurgery 2016; (78(2)):216-23 doi:10.1227/NEU.0000000000001011.
PMID: 26348007
10
Outcome of Microscopic Transsphenoidal Surgery in Cushing Disease: A Case Series of 96 Patients.
Shirvani M, Motiei-Langroudi R, Sadeghian H
World neurosurgery 2016; (87()):170-5.
PMID: 26704208
11
Normalized Early Postoperative Cortisol and ACTH Values Predict Nonremission After Surgery for Cushing Disease.
Asuzu D, Chatain GP, Hayes C, et al.
The Journal of clinical endocrinology and metabolism 2017; (102(7)):2179-2187 doi:10.1210/jc.2016-3908.
PMID: 28323961
12
Invasive ACTH-secreting pituitary macroadenoma in remission after transsphenoidal resection: A case report and literature review.
Zhuang Z, Liu X, Bao X, et al.
Medicine 2018; (97(46)):e13148 doi:10.1097/MD.0000000000013148.
PMID: 30431585
13
Suprasellar Tension Pneumatocele after Endoscopic Transsphenoidal Surgery for Pituitary Macroadenoma.
Sharma AK, Mehta R, Chandrakar N, et al.
Asian journal of neurosurgery 2020; (15(3)):763-765 doi:10.4103/ajns.AJNS_253_19.
PMID: 33145250
14
Medical treatment of functional pituitary adenomas, trials and tribulations.
Capatina C, Hanzu FA, Hinojosa-Amaya JM, Fleseriu M
Journal of neuro-oncology 2024; (168(2)):197-213 doi:10.1007/s11060-024-04670-x.
PMID: 38760632
15
Improvement in clinical features of hypercortisolism during osilodrostat treatment: findings from the Phase III LINC 3 trial in Cushing's disease.
Pivonello R, Fleseriu M, Newell-Price J, et al.
Journal of endocrinological investigation 2024; (47(10)):2437-2448 doi:10.1007/s40618-024-02359-6.
PMID: 38696122

This page explains surgical treatment options and recovery for Cushing disease for educational purposes only. Always consult your endocrinologist and neurosurgeon to discuss the best treatment plan and recovery expectations for your specific condition.

Get notified when new evidence is published on Cushing disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Guide Contents